Lv1
30 积分 2024-07-01 加入
Trends in the drug target landscape for autoimmune diseases
2天前
已完结
Trends in the drug target landscape for autoimmune diseases
2天前
已完结
Sequential immunotherapy: towards cures for autoimmunity
21天前
已完结
Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4+ T cells as predictors for response to integrin α4β7-blocking therapy in inflammatory bowel disease
22天前
已完结
SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
22天前
已完结
TSLP: from allergy to cancer
23天前
已完结
TSLP signaling in CD4 + T cells programs a pathogenic T helper 2 cell state
23天前
已完结
Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
1个月前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
1个月前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
1个月前
已完结
皖公网安备34019202002308
